Month: February 2026

Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis

During year 5 of treatment with BRIUMVI the annualized relapse rate was 0.020, equivalent to one relapse occurring every 50...

Functional Brands Inc. Introduces Kirkman’s(R) Exciting New Restorative Sleep Bundle for Deep, Refreshing Sleep Without Grogginess

A Science-Backed Solution to Support Relaxation and Nervous System BalanceLake Oswego, Oregon--(Newsfile Corp. - February 17, 2026) - Functional Brands...

Optimi Health Reports First MDMA-Assisted Treatments of 2026 are Underway Across an Expanded Network of Australian Clinics

MDMA-assisted therapy for PTSD delivered through Optimi's direct-to-clinic supply model under Australia's Authorised Prescriber SchemeVancouver, British Columbia--(Newsfile Corp. - February...

Precision AQ expands senior leadership team to strengthen global AI, data strategy, evidence synthesis and economic modelling capabilities

NEW YORK, Feb. 17, 2026 /PRNewswire/ -- Precision AQ, a global commercialisation partner built to guide life science innovators through commercial complexity,...

BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis

VANCOUVER, BC / ACCESS Newswire / February 17, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience...

Healthcare Predictive Analytics Market to Reach $128.2 Billion by 2033 Globally, at 24.3% CAGR: Allied Market Research

The global healthcare predictive analytics market is experiencing growth due to several factors such as convergence of data availability, technological...

error: Content is protected !!